Safety and Toxicology Study of Hu7691, a Novel AKT Inhibitor, following Oral Administration in Rats
Hu7691 represents a novel Pan-Akt kinase inhibitor, demonstrating excellent selectivity towards non-AGC kinase families and pronounced inhibitory effects on the proliferation of multiple tumor cell lines. However, there is currently a notable absence of in vivo toxicological research evidence concer...
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
MDPI AG
2023-10-01
|
| Schriftenreihe: | Toxics |
| Schlagworte: | |
| Online Zugang: | https://www.mdpi.com/2305-6304/11/11/880 |